Phase I/II pharmacokinetic multi-tumor study of subcutaneous formulation of nivolumab monotherapy

Project: Research project

Project Details

Description

Phase I/II pharmacokinetic multi-tumor study of subcutaneous formulation of nivolumab monotherapy
StatusFinished
Effective start/end date2/1/191/30/20

Funding

  • BRISTOL-MYERS SQUIBB COMPANY

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.